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Introduction
Bell’s palsy accounts for approximately half the peripheral 
facial nerve paralyses with the incidence at about 20 per 
100 000 adults per year in western countries (Adour et al 
1978, Peitersen 1982, Devriese et al 1990). Other causes 
of facial nerve paralysis include accidental and operative 
trauma, Herpes zoster oticus, or acute otitis media in 
children and chronic otitis media in adults. Complete 
recovery of facial function in Bell’s palsy occurs in 70% 
of people within three months (Peitersen 1994) with about 
30% of people continuing to suffer facial asymmetry at rest 
and during movement, as well as synkinesis. It is generally 
believed that spontaneous recovery of the facial nerve 
continues until about nine months. To minimise the impact 
of spontaneous recovery, this study included only people 
with a facial nerve paresis lasting more than nine months.
The sequelae of long-term facial asymmetry include 
difficulty with drinking, eating and speaking, and 
psychosocial problems (Devriese 1998). Facial symmetry 
is a determinant of facial attractiveness, being a marker of 
good health, and influences interpersonal attraction (Fink 
and Penton-Voak 2002, Heymans 2005). People suffering 
the sequelae of facial nerve paresis may be referred to 
physiotherapists since the medical practitioner’s options are 
limited to invasive treatments such as injection of Botulinum 
toxin A and surgical reconstruction (Beurskens et al 2005). 
Although a variety of physiotherapy interventions have been 
used to treat facial nerve paresis (Beurskens et al 2004a), 
randomised controlled trials have found no evidence in 
favour of one intervention over another (Mosforth and 
Taverner 1958: electrotherapy vs massage; Ross et al 1991: 
EMG-biofeedback vs mirror-feedback; Segal et al 1995a: 
‘small-movement-therapy’ vs exercise). Around 1980, 
mime therapy was developed in the Netherlands specifically 
for people with facial nerve paresis through collaboration 
between medical clinicians and mime-actors (Devriese and 
Bronk 1977). Two decades of positive experiences in several 
Dutch university medical centres have shaped mime therapy 
into its present form (Beurskens et al 2004b, Beurskens and 
Heymans 2004).
To investigate the effectiveness of mime therapy in reducing 
facial asymmetry in people with long-term peripheral facial 
nerve paresis, we conducted a randomised, controlled trial. 
In contrast to previous trials, being placed on a waiting 
list was chosen as the control, because there is minimal 
evidence for physiotherapy intervention after facial nerve 
paresis. Our main hypothesis was that mime therapy would 
improve facial symmetry both at rest and during voluntary 
movement, as well as reduce synkinesis, more than being 
placed on a waiting list.
Method
Design  The effectiveness of mime therapy was tested using 
a prospective randomised design with pre-and post-tests. 
The first author checked referral files against the inclusion 
criteria. A coin flip, by an independent administrative 
worker, designated the assignment to the mime therapy 
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(experimental) or waiting list (control) group for the first 
member of a pair as people with facial nerve paresis became 
available over time. In this way, the sequence of allocation 
was concealed from the recruiter. After pre-test, a participant 
was invited either to begin three months of treatment 
if allocated to the experimental group, or to make an 
appointment for treatment in three months time if allocated 
to the control group. At pre- and post-tests, video recordings 
of the participants were made by their physiotherapists using 
standardised positioning, facial tasks, and instructions. The 
first author scored the videotapes after all data had been 
collected. To ensure that the scorer remained blind to both 
the time of testing and the group assignment, the order in 
which the tapes were scored was randomised. The study was 
approved by the Advisory Committee on Ethics in Human 
Experimentation at the Radboud University Nijmegen 
Medical Centre.
Participants  People with peripheral facial nerve paresis were 
recruited from the physiotherapy outpatient departments of 
the Radboud University Nijmegen Medical Centre or the 
‘Vrije Universiteit’ Medical Centre Amsterdam. Referrals 
were made by general practitioners, ear, nose and throat 
specialists, plastic surgeons, and neurologists. People with 
facial nerve paresis were included in the trial if they were 
18 years or older, had a unilateral peripheral facial nerve 
paresis lasting more than nine months but not congenital in 
origin, and had sufficient knowledge of the Dutch language 
to participate in the trial. They were excluded if they had had 
surgical reconstruction (nerve or muscle reconstruction).
Intervention  Participants allocated to the experimental 
group were administered mime therapy by five trained 
physiotherapists. Participants were treated on an individual 
basis. Ten 45-min sessions of mime therapy were delivered 
about once a week over three months. A home program to 
be carried out for 30 min every day was also prescribed.
Mime therapy is a combination of mime and physiotherapy 
and aims to promote symmetry of the face at rest and 
during movement and to control synkinesis (Beurskens et 
al 2004b). First, participants were taught to massage their 
face and neck daily for 10–15 min. Massage consisted of 
effleurage and kneading both sides of the face. Stretching 
exercises of the affected side followed to relieve mimetic 
muscles involved in synkinesis. Then, participants were 
taught to recognise tension and to feel the difference between 
tension and relaxation in general and more specifically in 
the facial musculature, because synkinesis may increase 
muscle tone which can be exacerbated by stress. Third, 
specific exercises to co-ordinate both halves of the face 
and to decrease synkinesis were taught. Basic exercises 
(forehead wrinkle, eye closure, smile, snarl, lip pucker) 
with variations in amplitude and speed, exercises for one 
side of the face to control separate movements, relaxation 
of the lower jaw, exercises of the mouth (smiling, pouting) 
and the eye with simultaneous inhibition of synkinesis 
(slow, small movements and counteraction) were included. 
A mirror was used for feedback. Fourth, eye and lip closure 
exercises were taught. In cases of lagophthalmus (inability 
to close the eyelids fully) the upper eyelids were stretched. 
Eye exercises were performed with variations in speed and 
force, whilst keeping the lips still. Lip closure exercises 
comprised exercises of the cheek (filling the cheeks with 
varying amounts of air) and eating and drinking exercises 
whilst keeping the affected eye open (small movements). 
Fifth, exercises were performed to increase the participant’s 
awareness of lip movements and the position of the mouth 
for various sounds. Vowels as a, e, i, and o, and consonants 
such as p and b were used for the position of the lips. 
Lastly, expression exercises were taught. Mime therapy 
aims to develop a conscious connection between the use of 
certain muscles and facial emotional expression. Exercises 
were performed in two ways: working from the use of 
certain muscles towards an expression, or working from an 
expression as a starting point for a movement. For example: 
the participant was asked to raise the forehead or to perform 
an expression depicting amazement. Other expressions 
were evoked by asking the participant to: open the eyes 
wide (surprise), lift the upper lip (disgust), or tighten the 
lips (anger).
Participants allocated to the control group were placed on a 
waiting list for three months.
Outcome measures  The primary outcome measure was facial 
symmetry measured using the 13-item Sunnybrook Facial 
Grading System (Ross et al 1992). The system measures 
three components of facial asymmetry: resting asymmetry, 
symmetry of voluntary movement, and synkinesis. Resting 
asymmetry of the eye, cheek (nasolabial fold) and mouth 
are collectively scored from 0 to 4 with 4 being the most 
asymmetrical. Symmetry of the voluntary movements 
– forehead wrinkle, gentle eye closure, open mouth smile, 
snarl, and lip pucker – are each scored from 1 to 5 with 
5 being the most symmetrical, giving a total range of 5 to 
25. Synkinesis during the voluntary movements – forehead 
wrinkle, gentle eye closure, open mouth smile, snarl, and 
lip pucker – are each scored from 0 to 3 with 3 being the 
most synkinetic, giving a total range of 0 to 15. A composite 
facial symmetry score is calculated as
[4 × symmetry of voluntary movement – 5 × resting 
asymmetry + 1 × synkinesis]
with 100 representing normal facial symmetry. The 
Sunnybrook Facial Grading System has high reliability 
(Ross and Nedzelski 1998, Brach et al 1997, Beurskens et 
al 2004c).
The secondary outcome measure was severity of paresis 
measured using the House-Brackmann Facial Grading 
System. The House-Brackmann Facial Grading System 
consists of six grades, where Grade 1 represents normal 
function and Grade VI represents total paralysis. It is one 
of the most widely used scales and has been shown to have 
good inter-rater reliability; however, its sensitivity to change 
in facial symmetry is low (Evans et al 1989, Coulson et al 
2005).
Therapists scored their patients in vivo and these scores 
were compared to the scores from the video recordings 
made by the first author (CB) who was blind to group 
assignment, in order to evaluate the effect of video recording 
on measurement. Both scores were highly correlated for 
the Sunnybrook Facial Grading System (composite score: 
Pearson’s r = 0.93; resting asymmetry: r = 0.77; symmetry 
of voluntary movement: r = 0.91; synkinesis: r = 0.88) and 
the House-Brackmann Facial Grading System (Spearman’s 
R = 0.84). These values have a similar magnitude to the 
Intraclass Correlation of the three components of the 
Sunnybrook Facial Grading System in a comparable Dutch 
sample (Beurskens et al 2004). The analyses are all based 
on the blinded scorings.
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Data analysis  Only observed differences (between the 
experimental and control group and between pre- and post-
tests) consistent with the direction specified by our hypothesis 
were tested for their statistical significance (ie, using one-
sided statistical tests). To guarantee the clinical significance 
of the efficacy of mime therapy we were interested only in 
large effects, ie, a standardised mean difference of at least 
Cohen’s d = 0.80. Consultation of Woodward’s Table B7 
(Woodward 1999) indicated that, with the two-group design 
and a directional hypothesis, with 48 participants we would 
have 90% power to detect an effect size of 0.85 with a 
significance level of 5%. As protection against dropouts the 
sample was fixed at 50 people, 25 in each group.
The equivalence of the experimental and control groups at 
pre-test was tested with two-tailed t-tests and chi-square 
tests. Group differences at post-test provide the basis for 
conclusions about the effect of intervention. Preceding 
all effect-related statistical tests, group means at post-
test were checked as to whether they were not worse in 
the experimental group than in the control group. For the 
House-Brackmann Facial Grading System score, mean (SD) 
values are reported but group differences were analysed 
using a non-parametric test, ie, Mann-Whitney test. For 
the Sunnybrook Facial Grading System composite score, 
an analysis of covariance was performed using the pre-test 
score as covariate. For the three Sunnybrook Facial Grading 
System components, a multivariate analysis of covariance 
was performed, followed by single variable F tests. This 
was done to avoid an undue inflation of type 1 error rate 
with the pre-test scores as covariates. Standardised effect 
sizes (Hedges’s g) were then estimated in those cases 
where group differences were significant (p < 0.05). The 
(in)dependence of the effect of intervention from sex, age, 
and duration of the paralysis was examined by examining 
the interactions from three two-way analyses of variance 
(sex by group, age by group, duration of paresis by group). 
Finally, an analysis of the effect of intervention at the item 
level of the Sunnybrook Facial Grading System was carried 
out using a multivariate analysis of covariance, with the pre-
Assessment for eligibility,  
April 1999 – 30 November 2001, in 
Nijmegen and Amsterdam (n=162)
Did not meet inclusion criteria (n = 112), reasons:
 Refused to participate (n = 6)
 Too young (n = 21)
 Too early referral (n = 55)
 Complete paralysis (n = 5)
   Muscle/nerve reconstruction (n=23)
   Bilateral facial nerve paresis (n=2)
Allocated to waiting list (n = 25)
 Received allocated intervention (n = 24)
   Did not receive allocated intervention  (n=1) 
    Reason: terminally ill husband
Allocated to mime therapy (n = 25)
 Received allocated intervention (n = 24)
    Did not receive allocated intervention  (n=1) 
    Reason: pregnancy, bed rest
Analysed (n = 24)
Excluded from analysis (n = 1).
  Reason: dropout not related to group 
condition
Analysed (n = 24)
Excluded from analysis (n = 1)
  Reason: dropout not related to group 
condition
Random assignment (n = 50)
Figure 1.  Flow of participants through the trial.
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Table 1.  Mean (SD) score, mean (SD) difference within groups, and mean (95% CI) difference between groups of all 
outcomes for the experimental (n = 24) and control group (n = 24).
Outcome
Score Difference within groups Difference between 
groups in changes 
Month 0 Month 3 Month 3 minus Month 0 Month 3 minus Month 0
Exp Con Exp Con Exp Con Exp minus Con
HB–FGS
(1 to 6)
4.2
(0.8)
3.8
(0.8)
3.3
(0.8)
3.9
(0.8)
–0.9
(0.3)
0.0
(0.2)
–0.9
(–1.1 to –0.8)
SB–FGS Composite 
(0 to 100)
34.2
(19.0)
35.3
(17.6)
54.9
(18.2)
34.5
(16.2)
20.7
(7.9)
–0.8
(3.6)
21.5
(17.9 to 25.1)
SB–FGS
Resting asymmetry
(0 to 20)
12.3
(3.3)
11.5
(5.1)
7.1
(3.9)
11.9
(4.9)
–5.2
(3.5)
0.4
(2.8)
–5.6
(–7.4 to –3.8)
  Eye 
(0 to 1)
0.71
(0.46)
0.83
(0.38)
0.71
(0.46)
0.71
(0.46)
0.00
(0.7)
–0.13
(0.5)
0.13
(–0.22 to 0.48)
  Cheek 
(0 to 2)
0.71
(0.46)
0.83
(0.48)
0.46
(0.51)
0.79
(0.51)
–0.25
(0.5)
0.0
(0.4)
–0.25
(–0.51 to 0.01)
  Mouth 
(0 to 1)
0.88
(0.34)
0.75
(0.44)
0.25
(0.44)
0.88
(0.34)
–0.63
(0.5)
0.07
(0.1)
–0.70
(–0.91 to –0.49)
SB–FGS
Symmetry vol movt 
(20 to 100)
53.8
(17.1)
55.0
(14.7)
66.7
(15.3)
54.8
(14.2)
12.8
(7.2)
–0.2
(2.8)
13.0
(9.8 to 16.2)
  Forehead wrinkle 
(1 to 5)
2.4
(1.4)
2.5
(1.3)
2.6
(1.5)
2.4
(1.3)
0.3
(0.7)
–0.1
(0.3)
0.4
(0.1 to 0.7)
  Gentle eye closure 
(1 to 5)
3.5
(0.8)
3.5
(0.9)
4.0
(0.7)
3.7
(0.9)
0.4
(0.5)
0.1
(0.4)
0.3
(0.0 to 0.6)
  Open mouth smile 
(1 to 5)
2.4
(1.0)
2.6
(0.9)
3.5
(0.9)
2.6
(0.9)
1.1
(0.7)
0.0
(0.6)
1.1
(0.7 to 1.5 )
  Snarl 
(1 to 5)
2.5
(1.1)
2.2
(0.9)
3.2
(1.0)
2.3
(0.9)
0.7
(0.8)
0.0
(0.6)
0.7
(0.3 to 1.1)
  Lip pucker 
(1 to 5)
2.6
(1.0)
2.8
(0.8)
3.4
(0.8)
2.8
(0.8)
0.8
(0.7)
0.0
(0.5)
0.8
(0.5 to 1.2)
SB–FGS
Synkinesis 
(0 to 15)
7.6
(2.7)
7.8
(3.2)
4.9
(1.8)
8.0
(3.5)
–2.7
(1.9)
0.3
(2.6)
–3.0
(–4.3 to –1.7)
  Forehead wrinkle 
(0 to 3)
1.5
(0.9)
1.5
(0.8)
1.0
(0.6)
1.7
(0.9)
–0.5
(0.8)
0.1
(0.7)
–0.6
(–1.0 to –0.2)
  Gentle eye closure 
(0 to 3)
1.2
(0.7)
1.4
(0.7)
0.8
(0.5)
1.4
(0.7)
–0.4
(0.5)
0.0
(0.5)
–0.4
(–0.7 to –0.1)
  Open mouth smile 
(0 to 3)
1.3
(0.8)
1.3
(0.9)
0.8
(0.5)
1.7
(0.9)
–0.5
(0.3)
0.3
(0.6)
–0.8
(–1.1 to –0.5)
  Snarl 
(0 to 3)
1.5
(0.7)
1.6
(0.7)
0.8
(0.6)
1.6
(0.8)
–0.7
(0.7)
0.0
(0.5)
–0.7
(–1.1 to –0.4)
  Lip pucker 
(0 to 3)
2.0
(0.8)
2.0
(0.9)
1.4
(0.7)
2.1
(0.9)
–0.6
(0.5)
0.1
(0.5)
–0.7
(–1.0 to –0.4)
Exp = mime therapy, Con = waiting list; HB-FGS = House-Brackmann Facial Grading System; SB-FGS = Sunnybrook Facial 
Grading System
test scores as covariates. Sensitivity of the results to dropout 
was tested by a ‘worst-case’ scenario, in which the dropout 
in the experimental group was assigned the worst observed 
outcome, and the dropout in the control group assigned the 
best observed outcome in their group.
Results
Flow of participants through the trial  Recruitment in 
both physiotherapy departments started in April 1999. It 
ended in November 2001 when 50 people with facial nerve 
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Table 2.  Number (%) of experimental (n = 24) and control participants (n = 24) that improved, did not change, and got worse 
for all outcomes by 3 months.
Outcome Improved Did not change Got worse
Exp Con Exp Con Exp Con
HB-FGS 21
(88)
0
(0)
3
(12)
23
(96)
0
(0)
1
(4)
SB-FGS
Composite
24
(100)
9
(38)
0
(0)
2
(8)
0
(0)
13
(54)
SB-FGS
Resting asymmetry 20
(83)
2
(8)
4
(17)
19
(79)
0
(0)
3
(12)
 Eye 5
(21)
5
(21)
14
(58)
17
(71)
5
(21)
2
(8)
 Cheek 7
(29)
2
(8)
16
(67)
21
(88)
1
(4)
1
(4)
        Mouth 15
(63)
0
(0)
9
(38)
21
(88)
0
(0)
3
(12)
SB-FGS
Symmetry vol movt 23
(96)
5
(21)
1
(4)
13
(54)
0
(0)
6
(25)
 Forehead wrinkle 8
(33)
0
(0)
15
(63)
22
(92)
1
(4)
2
(8)
 Gentle eye closure 10
(42)
2
(8)
14
(58)
22
(92)
0
(0)
0
(0)
 Open mouth smile 19
(79)
3
(12)
5
(21)
19
(79)
0
(0)
2
(8)
 Snarl 13
(54)
3
(12)
11
(46)
18
(75)
0
(0)
3
(12)
 Lip pucker 16
(67)
3
(12)
8
(33)
19
(79)
0
(0)
2
(8)
SB-FGS
Synkinesis 21
(88)
2
(8)
2
(8)
9
(38)
1
(4)
13
(54)
 Forehead wrinkle 12
(50)
5
(21)
11
(46)
11
(46)
1
(4)
8
(33)
 Gentle eye closure 10
(42)
3
(12)
14
(58)
18
(75)
0
(0)
3
(12)
 Open mouth smile 13
(54)
1
(4)
8
(33)
15
(63)
3
(12)
8
(33)
 Snarl 16
(67)
2
(8)
7
(29)
19
(79)
1
(4)
3
(12)
 Lip pucker 14
(58)
1
(4)
10
(42)
21
(88)
0
(0)
2
(8)
Exp = mime therapy, Con = waiting list; HB-FGS = House-Brackmann Facial Grading System; SB-FGS = Sunnybrook Facial 
Grading System
paresis (21 males and 29 females; mean age 44 years, 
SD 14, range 20–73) met the inclusion criteria and had 
consented to participate in the study (Figure 1). The causes 
of facial nerve paresis were Bell’s palsy (n = 34); acoustic 
neuroma operation (n = 6), Herpes zoster oticus (n = 5), 
accidental trauma (n = 3), operative trauma (n = 1) and 
Lyme disease (n = 1). The median time between onset of 
the paralysis (divided equally between left and right sides) 
and admission to the trial was 13 months (range 10–480). 
The average severity of the paresis on admission to the 
trial was Grade 4 for the House-Brackmann Facial Grading 
System (SD 0.8, range 2–5), and facial symmetry was 35 
for the Sunnybrook Facial Grading System (SD 18, range 
6–70). Most people were referred by an otolaryngologist. 
Twenty-five participants were allocated to the experimental 
group and 25 to the control group. Groups did not differ 
significantly in sex, age, referral, cause of paresis, severity 
of paresis, affected side, and time interval between the 
paralysis and the referral. The groups also did not differ 
significantly at pre-test with regard to the outcome measures 
(Table 1). There was one dropout in each group: one patient 
was pregnant and obliged to maintain bed rest (after five 
treatment sessions), the other (on the waiting list) because 
of nursing her terminally ill husband (Figure 1).
Effect of intervention The mean (SD) of all outcome 
measures pre- and post-test are presented in Table 1. The 
number (%) of participants who improved, did not change, 
or got worse for all measures is presented in Table 2.
After three months of mime therapy, the experimental group 
had improved their facial symmetry by 20.4 points (95% CI 
10.4 to 30.4, p < 0.001) on the Sunnybrook Facial Grading 
System compared with the control group when determined 
using ANCOVA with the pre-test score as a covariate, or 
21.5 points (95% CI 17.9 to 25.1) when determined directly 
from the change scores. This overall difference was based 
upon significant between-group differences for each of 
the three Sunnybrook Facial Grading System components 
(resting asymmetry: p < 0.001; symmetry of voluntary 
movement: p < 0.001; synkinesis: p < 0.001). Furthermore, 
there were significant between-group differences for 12 of 
the 13 items in favour of the experimental group. Resting 
asymmetry of the eye was the only item not affected by 
mime therapy. The same pattern of results was obtained 
when we included dropout scores estimated according to 
the worst-case scenario. Examination of the standardised 
between-group effect sizes after adjustment for pre-test 
scores show that they are substantial. The effect size is g = 
3.6 for the composite score, g = 1.8 for resting asymmetry, 
g = 2.5 for symmetry of voluntary movement, and g = 1.5 
for synkinesis.
After three months of mime therapy, the experimental 
group had reduced the severity of their paresis by 0.6 grade 
(95% CI –1.1 to –0.1, p = 0.01) on the House-Brackmann 
Facial Grading System compared with the control group 
when determined using ANCOVA with the pre-test score 
as a covariate, or 0.9 grade (95% CI –1.1 to –0.8) when 
determined directly from the change scores.
These effects were independent of age, sex, and duration of 
paresis. The age variable was trichotomised (below 35, 35–
50, above 50 years). Duration of paresis was dichotomised 
at the median (13 months). No significant interactions of 
intervention with sex, age, or duration of paresis were 
found for the Sunnybrook Facial Grading System or its 
three components. The effects of mime therapy appear to 
be similar for both sexes, across the three age groups, and 
regardless of duration of paresis.
The analyses have shown that mime therapy is effective. 
The possibility exists that both groups show a differential 
but detrimental change, instead of the clinically desired 
improvement. Examination of the within-group and 
between-group means presented in Table 1 show that there 
was an improvement in facial symmetry during voluntary 
movement and a reduction in facial asymmetry, synkinesis, 
and the severity of paresis from pre-test to post-test for 
all outcomes except one (resting asymmetry of the eye). 
Furthermore, examination of the individual participants 
presented in Table 2 shows that the majority of people 
benefit from mime therapy. Facial symmetry improved in 
100% of the experimental group compared with 38% of the 
control group. Severity of paresis was reduced in 88% of the 
control group compared with 0% of the control group.
Discussion
The main goal of this research was to determine whether 
mime therapy would improve facial symmetry. The results 
support our hypothesis that mime therapy substantially 
improves facial symmetry in people with long-term facial 
nerve paresis. There were greater improvements in the 
Sunnybrook Facial Grading System for all three components 
of facial symmetry in the group that received mime therapy 
compared with the group on the waiting list. Similar 
improvements were present in the House-Brackmann Facial 
Grading System. After mime therapy, facial asymmetry at rest 
and synkinesis decreased and facial symmetry of voluntary 
movement increased. That is, the facial appearance of the 
majority of people improved as a consequence of mime 
therapy. This therapy can be generalised across sex, age, 
and duration of the paresis as it has been tested on people 
with long-term facial nerve paresis who are similar to the 
patients who have been seen by both outpatient departments 
for more than ten years.
The effect sizes are large and therefore clinically relevant. 
Three months of mime therapy improved facial symmetry 
by 20 points on the Sunnybrook Facial Grading System 
compared with being placed on a waiting list, where 10 
points is considered clinically significant. This translates 
into large standardised effect sizes of 3.6 standard deviations 
after adjustment for pre-test scores and 1.8 standard 
deviations without adjustment for pre-test scores. Mime 
therapy also reduced the severity of paresis by 0.6 grade 
on the House-Brackmann Facial Grading System compared 
with being placed on a waiting list, which is also clinically 
significant. In contrast, non-randomised controlled trials 
using the House-Brackmann Facial Grading System report 
non significant pre-post differences (Coulson and Croxson 
1995, Segal et al 1995b).
It is possible that resentment from being placed on a waiting 
list may have had an effect on the control group. However, 
as waiting lists (from some weeks to several months) in the 
Dutch health care system are normal, people considered it 
‘normal’ that treatment would start after receiving a call 
from the hospital. Therefore, there is no indication that 
people in the mime therapy group felt ‘advantaged’, or that 
people in the waiting list groups felt ‘disadvantaged’.
Only one aspect of facial symmetry – eye asymmetry at rest 
– did not improve as a result of mime therapy. It appears that 
eye asymmetry in most people with facial nerve paresis is 
caused by a synkinetic tension of the orbicular oris muscle 
(64% of the participants had a small interpalpebral fissure). 
It may be more difficult for people to concentrate on the eye 
when trying to relax, than to concentrate on the mouth/cheek 
region where there are several muscles to focus upon.
Future research into mime therapy should aim to replicate 
the present results, assess the long-term effects of mime 
therapy, and examine its dose-response curve. The effects 
of mime therapy may also be examined in an early stage of 
the paresis. The relationship between facial asymmetry and 
psychosocial handicaps (such as impaired communication, 
low quality-of-life, and depression) could also be 
investigated. Finally, a study of the theoretical background 
responsible for the effectiveness of mime therapy (including 
an eventual placebo component) is recommended.
In conclusion, this is the first study that demonstrates 
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efficacy of mime therapy. It also demonstrates the sensitivity 
of the Sunnybrook Facial Grading System in measuring the 
effectiveness of intervention for people with facial nerve 
paresis. An improvement in resting asymmetry, symmetry 
of voluntary movement, and synkinesis, was expressed 
as a higher composite score of the Sunnybrook Facial 
Grading System and a lower House-Brackmann Facial 
Grading System. The effects are not dependent on age, sex, 
or duration of the paresis. The clinical implication is that 
mime therapy is a good treatment choice for people with 
long-term facial nerve paresis. The cost of the intervention 
is relatively low because the amount of professional support 
is small since a home program is an integral part of the 
treatment. Time spent with the therapist is only about 10 
hours. Training of physiotherapists and speech therapists 
to apply mime therapy is a good investment in providing 
professional care for people suffering the sequelae of long-
term facial nerve paresis.
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